NIMODIPINE
Generic: NIMODIPINE
Camber PharmaceuticalsManufacturer
ORALRoute
NIMODIPINEActive Substance
2024-07-09Original Approval
NIMODIPINE is FDA application ANDA216937, sponsored by ANNORA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
89 reports
2
OFF LABEL USE
69 reports
3
HYPOTENSION
57 reports
4
SUBARACHNOID HAEMORRHAGE
42 reports
5
DIZZINESS
33 reports
6
HEADACHE
33 reports
7
DRUG INTERACTION
32 reports
8
RENAL FAILURE
31 reports
9
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME
31 reports
10
CONDITION AGGRAVATED
29 reports